Faculty of medicine
Sohag, Egypt
Location status: Recruiting
Location contact
Alshimaa H Khalaf, Assistant lecturer
CONTACT
Esam M Abualfadl, Professor
CONTACT
Recruiting
NCT Number: NCT06718283
Assessment of Hematologic Indices in Juvenile Lupus Erythematosus Patients:Correlation With Disease Activity and Chronic Organ Damage in These Patients
The study aim to evaluate the relationship between some important hematologic indices in juvenile lupus erythematosus patients and if these indices may be use as markers of disease acitivity in these patients or not ,also evaluate the relationship with these markers and chronic organ damage index
Recruiting
Interested in participating?
Request InfoKey information
Conditions
Age range
Up to 18 year
Sex eligibility
All sexes
Study type
Observational
Primary location
About this study
We calculate important hematologic indices in children diagnosed as SLE as systemic inflamatory index ,systemic inflamatory response index and aggregate index of systemic inflamation in these patients ,and correlate these indices with SLE disease activity index and chronic damage index in these patients.
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- patients who fillful 2012 SLICC criteria or 2019 ACR/EULAR criteria of systemic lupus erythematosus
- Age of patients at disease onset before 18 years
Exclusion criteria
- Adult onset disease ( age at disease onset after 18 years
- Any other chronic inflamatory disorders or other autoimmune diseases
Treatment and study plan
Primary outcomes
-
Calculation of hematological indices in juvenile lupus erythematosus patients
Time frame: 3_ 6 months
Calculation of systemic inflamatory index,systemic information response index and aggregate index of systemic inflamation ,and correlate these indices to SLE disease activity index
-
Correlation between hematologic indices in juvenile lupus erythematosus patients and disease activity in these patients
Time frame: 3-6 months
SLEDAI score in juvenile lupus erythematosus patients
Secondary outcomes
-
Calculation of chronic damage index in juvenile lupus erythematosus patients
Time frame: 3_6 months
SLICC/ACR score in juvenile lupus erythematosus patients
-
Relationship between hematologic index and chronic organ damage index in juvenile lupus erythematosus patients
Time frame: 3-6 months
SLICC/ACR score
Study contacts
Contact information is provided by the study sponsor or research team.
Sponsors and collaborators
Lead sponsor
Sohag University
Other
Registry information
Official study title
Assessment of Hematologic Indices in Juvenile Lupus Erythematosus Patients : Correlation With Disease Activity and Chronic Organ Damage in These Patients
Important dates
- Study start
- 2024
- Primary completion
- 2025
- Study completion
- 2026
- First posted
- Dec 5, 2024
- Registry last updated
- Dec 5, 2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Recruiting
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
NCT07087912
Ankylosis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
São Paulo, Brazil
View Trial Details
Completed
Headache in Juvenile Onset Systemic Lupus Erythematosus
NCT06658457
Headache, Juvenile Systemic Lupus Erythematosus
Denizli, Turkey (Türkiye)
View Trial Details